The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.
Clinical trial NCT04328480 · COMPLETED
Trial details
- NCT number
- NCT04328480
- Sponsor
- Estudios Clínicos Latino América
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-17
- Primary completion
- 2021-04-25
- Enrollment
- 1279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.